Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Clinical trial NCT05923905 · RECRUITING

Trial details

NCT number: NCT05923905
Sponsor: Peking University Third Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sporadic and Familial Amyotrophic Lateral Sclerosis

Start date: 2023-01-18
Primary completion: 2027-09-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.